LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Molecular Assay Compared to Blood Smear for Babesiosis Diagnosis

By LabMedica International staff writers
Posted on 10 Jun 2015
Image: Photomicrograph of a thin blood smear showing different stages of Babesia microti in erythrocytes (Photo courtesy of the University of Utah).
Image: Photomicrograph of a thin blood smear showing different stages of Babesia microti in erythrocytes (Photo courtesy of the University of Utah).
A real-time quantitative polymerase chain reaction (qPCR) has been used to determine the number of DNA copies/mL of blood of a Babesia microti gene in infected patients.

Although microscopic examination of a peripheral blood smear is the most commonly used diagnostic method to diagnose active Babesia infection in symptomatic patients, polymerase chain reaction (PCR) assays are also being increasingly employed as well.

Scientists at New York Medical College (Valhalla, NY, USA) obtained blood samples from 36 patients whose median age was 62.5 years and 75.0% were male with at least one qPCR-positive blood sample were included in this analysis, including 16 with serial blood samples. Blood samples were evaluated by Wright or Giemsa-stained thick and thin blood smears with at least 300 oil immersion fields were examined on a thin blood smear before reporting a negative test result.

Extracted DNA was eluted from the blood samples using a commercial DNA extraction kit, the QIAamp DNA Blood Mini (Qiagen; Valencia, CA, USA) and qPCR was performed on the 7500 Fast Dx Real-Time PCR instrument (Applied Biosystems; Foster City, CA, USA). Of the 36 patients, 32 had one or more positive blood smears for ring forms consistent with B. microti, though not all of the blood samples with positive smears were simultaneously tested by qPCR.

Based on testing of serial blood samples, it was demonstrated that the smear became negative while the qPCR remained positive. A moderate to strong correlation was found between the DNA copy number and the number of infected erythrocytes per milliliter of blood. Based on limited data, the DNA copy number fell by a mean of 4.1% to 12.9% per day on active treatment and by 3.5% to 7.1% per day off therapy.

The authors concluded that the qPCR method is more sensitive than microscopic examination of the blood smear for detection of B. microti infection. This assay should enable an assessment of the rate of parasite clearance over time even in patients who have become smear negative. Quantitative test results for parasite clearance may be useful in evaluating the relative efficacy of various antiparasitic drug regimens and other therapeutic modalities. The study was published in the June 2015 issue of the journal Diagnostic Microbiology and Infectious Disease.

Related Links:

New York Medical College
Qiagen 
Applied Biosystems 


New
Gold Member
Clinical Drug Testing Panel
DOA Urine MultiPlex
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Automated Chemiluminescence Immunoassay Analyzer
MS-i3080
Clinical Chemistry System
P780

Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more